What's new

Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 May 2025, 12:30 (CEST) to 22 May 2025, 17:30 (CEST)

Clinical Trials Information System (CTIS): Information ...

Mar 28, 2025 0

Clinical Trials Information System (CTIS): Information day, Online, European Med...

Policy 85: Identity and Access Management to EMA IT Sys...

Mar 28, 2025 0

Policy 85: Identity and Access Management to EMA IT Systems

Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Laventair Ellipta (pre...

Human medicines European public assessment report (EPAR): Anoro Ellipta (previously Anoro), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Anoro Ellipta (previou...

Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date of authorisation: 20/08/2015, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Respreeza, alpha1-prot...

Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Dat...

Human medicines European public assessment report (EPAR): VeraSeal, human fibrinogen,human thrombin, Date of authorisation: 10/11/2017, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): VeraSeal, human fibrin...

Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, D...

Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Date of authorisation: 15/10/2015, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Cresemba, isavuconazol...

Human medicines European public assessment report (EPAR): Febuxostat Krka, febuxostat, Date of authorisation: 28/03/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Febuxostat Krka, febux...

Human medicines European public assessment report (EPAR): INOmax, nitric oxide, Date of authorisation: 01/08/2001, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): INOmax, nitric oxide, ...

Minutes of the COMP meeting 18-19 February 2025

Mar 27, 2025 0

Minutes of the COMP meeting 18-19 February 2025

Human medicines European public assessment report (EPAR): Reagila, cariprazine, Date of authorisation: 13/07/2017, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Reagila, cariprazine, ...

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (17...

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab,...

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Date of authorisation: 24/04/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Da...

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025 0

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept...

Fields and business rules for the European Shortages Mo...

Mar 27, 2025 0

Fields and business rules for the European Shortages Monitoring Platform (ESMP) ...

European shortages monitoring platform (ESMP) API - Ins...

Mar 27, 2025 0

European shortages monitoring platform (ESMP) API - Instructions to request acce...

European shortages monitoring platform (ESMP) API - Req...

Mar 27, 2025 0

European shortages monitoring platform (ESMP) API - Request access to ESMP API f...

European Shortages Monitoring Platform (ESMP) open Appl...

Mar 27, 2025 0

European Shortages Monitoring Platform (ESMP) open Application Programming Inter...

Guidance for Rapporteurs and members of drafting groups...

Mar 27, 2025 0

Guidance for Rapporteurs and members of drafting groups of documents developed b...

Three year work plan for the Good Manufacturing Practic...

Mar 27, 2025 0

Three year work plan for the Good Manufacturing Practice / Good Distribution Pra...

Annual report of the Good Manufacturing and Distributio...

Mar 27, 2025 0

Annual report of the Good Manufacturing and Distribution Practice Inspectors Wor...

15
16
17
18
19

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.